Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54,193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Structural insight into CD93 recognition by IGFBP7.
Xu Y, Sun Y, Zhu Y, Song G. Xu Y, et al. Among authors: zhu y. Structure. 2024 Mar 7;32(3):282-291.e4. doi: 10.1016/j.str.2023.12.011. Epub 2024 Jan 12. Structure. 2024. PMID: 38218180
BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells.
Yao C, Lou G, Sun HW, Zhu Z, Sun Y, Chen Z, Chauss D, Moseman EA, Cheng J, D'Antonio MA, Shi W, Shi J, Kometani K, Kurosaki T, Wherry EJ, Afzali B, Gattinoni L, Zhu Y, McGavern DB, O'Shea JJ, Schwartzberg PL, Wu T. Yao C, et al. Among authors: zhu y, zhu z. Nat Immunol. 2021 Mar;22(3):370-380. doi: 10.1038/s41590-021-00868-7. Epub 2021 Feb 11. Nat Immunol. 2021. PMID: 33574619 Free PMC article.
Author Correction: BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells.
Yao C, Lou G, Sun HW, Zhu Z, Sun Y, Chen Z, Chauss D, Moseman EA, Cheng J, D'Antonio MA, Shi W, Shi J, Kometani K, Kurosaki T, Wherry EJ, Afzali B, Gattinoni L, Zhu Y, McGavern DB, O'Shea JJ, Schwartzberg PL, Wu T. Yao C, et al. Among authors: zhu y, zhu z. Nat Immunol. 2021 Apr;22(4):530. doi: 10.1038/s41590-021-00906-4. Nat Immunol. 2021. PMID: 33658708 No abstract available.
Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy.
Sun Y, Chen W, Torphy RJ, Yao S, Zhu G, Lin R, Lugano R, Miller EN, Fujiwara Y, Bian L, Zheng L, Anand S, Gao F, Zhang W, Ferrara SE, Goodspeed AE, Dimberg A, Wang XJ, Edil BH, Barnett CC, Schulick RD, Chen L, Zhu Y. Sun Y, et al. Among authors: zhu g, zhu y. Sci Transl Med. 2021 Jul 28;13(604):eabc8922. doi: 10.1126/scitranslmed.abc8922. Sci Transl Med. 2021. PMID: 34321321 Free PMC article.
Group XIV C-type lectins: emerging targets in tumor angiogenesis.
Yee EJ, Vigil I, Sun Y, Torphy RJ, Schulick RD, Zhu Y. Yee EJ, et al. Among authors: zhu y. Angiogenesis. 2024 May;27(2):173-192. doi: 10.1007/s10456-024-09907-x. Epub 2024 Mar 12. Angiogenesis. 2024. PMID: 38468017 Free PMC article. Review.
GPCRs: emerging targets for novel T cell immune checkpoint therapy.
Dickinson K, Yee EJ, Vigil I, Schulick RD, Zhu Y. Dickinson K, et al. Among authors: zhu y. Cancer Immunol Immunother. 2024 Oct 3;73(12):253. doi: 10.1007/s00262-024-03801-7. Cancer Immunol Immunother. 2024. PMID: 39358616 Free PMC article. Review.
Atypical chemokine receptors: emerging therapeutic targets in cancer.
Torphy RJ, Yee EJ, Schulick RD, Zhu Y. Torphy RJ, et al. Among authors: zhu y. Trends Pharmacol Sci. 2022 Dec;43(12):1085-1097. doi: 10.1016/j.tips.2022.09.009. Epub 2022 Oct 26. Trends Pharmacol Sci. 2022. PMID: 36307250 Free PMC article. Review.
54,193 results
You have reached the last available page of results. Please see the User Guide for more information.